155 related articles for article (PubMed ID: 25487851)
21. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
Peles E; Schreiber S; Hetzroni T; Adelson M; Defrin R
J Pain; 2011 Jan; 12(1):41-50. PubMed ID: 20561825
[TBL] [Abstract][Full Text] [Related]
22. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
23. [Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China.].
Cao XB; Yin WY; Pang L; Zhang CB; Xu JS; Xiao YK; Wang CH; Luo W; Zhang B; Zhang RM; Li ZJ; Rou KM; Wu ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):269-72. PubMed ID: 20510050
[TBL] [Abstract][Full Text] [Related]
24. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
Martin TJ; Kahn WR; Xiao R; Childers SR
Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089
[TBL] [Abstract][Full Text] [Related]
25. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
26. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
Shariatirad S; Maarefvand M; Ekhtiari H
Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
[No Abstract] [Full Text] [Related]
27. QT length during methadone maintenance treatment: gene × dose interaction.
Zerdazi EH; Vorspan F; Marees AT; Naccache F; Lepine JP; Laplanche JL; Prince N; Marie-Claire C; Bellivier F; Mouly S; Bloch V
Fundam Clin Pharmacol; 2019 Feb; 33(1):96-106. PubMed ID: 30086202
[TBL] [Abstract][Full Text] [Related]
28. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
29. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
[TBL] [Abstract][Full Text] [Related]
30. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
Hoell I; Havemann-Reinecke U
Med Monatsschr Pharm; 2011 Oct; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
[TBL] [Abstract][Full Text] [Related]
31. A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi'an.
Wei X; Wang L; Wang X; Li J; Li H; Jia W
J Addict Med; 2013; 7(5):342-8. PubMed ID: 23896752
[TBL] [Abstract][Full Text] [Related]
32. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Ngo HT; Tait RJ; Hulse GK
J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
[TBL] [Abstract][Full Text] [Related]
33. Heroin maintenance treatment: from idea to research to practice.
Uchtenhagen AA
Drug Alcohol Rev; 2011 Mar; 30(2):130-7. PubMed ID: 21375613
[TBL] [Abstract][Full Text] [Related]
34. [Methadone and levomethadone - dosage and side effects].
Schoofs N; Riemer T; Bald LK; Heinz A; Gallinat J; Bermpohl F; Gutwinski S
Psychiatr Prax; 2014 Mar; 41(2):82-7. PubMed ID: 24254424
[TBL] [Abstract][Full Text] [Related]
35. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy.
Compton P; Canamar CP; Hillhouse M; Ling W
J Pain; 2012 Apr; 13(4):401-9. PubMed ID: 22424799
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological maintenance treatments of opiate addiction.
Bell J
Br J Clin Pharmacol; 2014 Feb; 77(2):253-63. PubMed ID: 23210630
[TBL] [Abstract][Full Text] [Related]
37. The marketing of methadone: how an effective medication became unpopular.
Bruce RD
Int J Drug Policy; 2013 Nov; 24(6):e89-90. PubMed ID: 24246504
[No Abstract] [Full Text] [Related]
38. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
Bramness JG; Bachs LC; Waal H
Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
[TBL] [Abstract][Full Text] [Related]
39. The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance.
Wang SC; Tsou HH; Chung RH; Chang YS; Fang CP; Chen CH; Ho IK; Kuo HW; Liu SC; Shih YH; Wu HY; Huang BH; Lin KM; Chen AC; Hsiao CF; Liu YL
J Clin Psychopharmacol; 2014 Apr; 34(2):205-11. PubMed ID: 24525640
[TBL] [Abstract][Full Text] [Related]
40. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
Soyka M; Limmer C; Lehnert R; Koller G; Martin G; Küfner H; Kagerer S; Haberthür A
Am J Drug Alcohol Abuse; 2011 Nov; 37(6):497-508. PubMed ID: 21851203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
